La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.
Published May 21, 2025 · Recall initiated: March 5, 2025
Summary
FDA records drug Class II recall D-0417-2025, published May 21, 2025 and initiated March 5, 2025. Recalling firm: L'Oreal USA; Status: Ongoing; Reported quantity: 2,226,801 bottles; Lot: Lot #: MYX46W, Exp 04/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- L'Oreal USA
- Distributor
- Nationwide in the USA
- UPC
- 883140500759
- Lot
- Lot #: MYX46W, Exp 04/30/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALa Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide AcneMay 21, 2025
- FDALa Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit,May 21, 2025
- FDATestosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial, Compounded by:May 21, 2025
- FDAIntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x; Model Number: 830089.May 14, 2025
- FDAGALT Guidewire REF SGW-051-07 Guidewires are intended for use in percutaneous procedures, to introduce andMay 14, 2025
- FDAB Braun Interventional Coaxial Dilator REF: KIT-018-47, KIT-019-67, KIT-018-41, KIT-019-37 TheseMay 14, 2025
Questions about this recall
Was La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759. recalled?
Yes. FDA published recall D-0417-2025 on May 21, 2025. Reported hazard: Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. UPC: 883140500759.